Cargando…

Cost-effectiveness of population-based screening for colorectal cancer

Detalles Bibliográficos
Autor principal:	O'Mahony, J F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619054/ https://www.ncbi.nlm.nih.gov/pubmed/23392083 http://dx.doi.org/10.1038/bjc.2012.490

Ejemplares similares

Reply: cost-effectiveness of population-based screening for colorectal cancer
por: Sharp, L, et al.
Publicado: (2013)

Colonoscopy colorectal cancer screening: Cost-effectiveness in Thailand
por: Joob, Beuy, et al.
Publicado: (2016)

Risk Stratification in Cost-Effectiveness Analyses of Cancer Screening: Intervention Eligibility, Strategy Choice, and Optimality
por: O’Mahony, James F.
Publicado: (2021)

A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?
por: Pokharel, Rajani, et al.
Publicado: (2023)

Interpreting cost-effectiveness ratios in a cost-effectiveness analysis of risk-tailored prostate screening: A critique of Callender et al.
por: O'Mahony, James F.
Publicado: (2020)

gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027
por: Drudy, Denise, et al.
Publicado: (2007)

Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021)

Cost-Effective Screening for Trichomoniasis
por: Schwebke, Jane R.
Publicado: (2002)

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R
por: Lin, Yi-Shu, et al.
Publicado: (2023)

Screening for colorectal cancer with immunological FOBT
por: Ottó, S, et al.
Publicado: (2004)

Differences in Family Involvement in the Bedside Care of Patients in the ICU Based on Self-Identified Race
por: Nunez, Eduardo R., et al.
Publicado: (2021)

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification
por: Fabbro, Matthew, et al.
Publicado: (2022)

Reply: Screening for colorectal cancer with immunological FOBT
por: Saito, Hiroshi, et al.
Publicado: (2004)

European principles of inhibitor management in patients with haemophilia: implications of new treatment options
por: Hermans, C., et al.
Publicado: (2020)

Cost-Effective Screening for Trichomoniasis—reply to Dr. Schwebke
por: Sorvillo, Frank, et al.
Publicado: (2002)

Genetic screening for neovascular AMD: cost effective…not so quick
por: Reichel, Elias
Publicado: (2015)

Is colorectal cancer screening necessary before 50 years of age?
por: Jung, Yoon Suk
Publicado: (2017)

Advocacy for colorectal cancer screening and awareness in people with intellectual disability
por: Satgé, Daniel, et al.
Publicado: (2023)

CRITICAL APPRAISAL OF THE CLINICAL TRIAL: EFFECT OF COLONOSCOPY SCREENING ON RISKS OF COLORECTAL CANCER AND RELATED DEATH
por: Bernardo, Wanderley Marques, et al.
Publicado: (2023)

Using of artificial intelligence: Current and future applications in colorectal cancer screening
por: Zacharakis, Georgios, et al.
Publicado: (2022)

A New Risk-Scoring System for Colorectal Cancer and Polyp Screening
por: Romanová, Alexandra, et al.
Publicado: (2022)

tRNA‐derived fragments are promising biomarkers for screening of early colorectal cancer
por: Dang, Yanqi, et al.
Publicado: (2023)

Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?
por: McFerran, Ethna, et al.
Publicado: (2022)

Genetic and epigenetic changes in the development of multiple colorectal cancers in the general population
por: Watanabe, T, et al.
Publicado: (2005)

Cost of blood screening.
por: Chang, O J
Publicado: (1998)

Comment on ‘Psychological distress in patients with cancer: is screening the effective solution?'
por: Dekker, J, et al.
Publicado: (2013)

Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
por: O'Farrell, Eoin, et al.
Publicado: (2019)

New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options?
por: Shastri, Y M, et al.
Publicado: (2007)

Colorectal screening: We have not caught up. A surge of colorectal cancer after the coronavirus disease 2019 (COVID-19) pandemic?
por: Challine, Alexandre, et al.
Publicado: (2021)

Cost-effectiveness of colorectal cancer screening in Ukraine
por: Melnitchouk, Nelya, et al.
Publicado: (2018)

Cost-effectiveness of Colorectal Cancer Screening
por: Lansdorp-Vogelaar, Iris, et al.
Publicado: (2011)

Small molecule inhibitors from organoid‐based drug screen induce concurrent apoptosis and gasdermin E‐dependent pyroptosis in colorectal cancer
por: Zhang, Yuchen, et al.
Publicado: (2022)

Cost-Effectiveness of Colorectal Cancer Screening Protocols in Urban Chinese Populations
por: Huang, Weidong, et al.
Publicado: (2014)

Re: “Colorectal screening: We have not caught up. A surge of colorectal cancer after the coronavirus disease 2019 (COVID-19) pandemic?”
por: Mak, Victoria P., et al.
Publicado: (2021)

Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
por: Karlitz, Jordan J., et al.
Publicado: (2022)

The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands
por: Dinmohamed, Avinash G., et al.
Publicado: (2020)

Ethical dilemma of colorectal screening: What age should a screening colonoscopy start and stop?
por: Turshudzhyan, Alla, et al.
Publicado: (2021)

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”
por: Kregting, Lindy M., et al.
Publicado: (2022)

Screening and the costs of treating colorectal cancer.
por: Whynes, D. K., et al.
Publicado: (1993)

Burden of health‐care costs for patients with heparin replacement for colorectal EMR in Japan
por: Hayashi, Shiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uk9nav7vut983m6noh7m91h52v